The City has a number of COVID-19 immunization clinics. Learn more about where to get vaccinated.

For the latest updates on COVID-19, please subscribe to the Communiqué e-newsletter.

See the Ontario Ministry of Health’s COVID-19 Reference Document for Symptoms .

See the Ontario Ministry of Health’s Current Case Definition for COVID-19.

Toronto Public Health continues to actively monitor the situation in collaboration with provincial and national health agencies and stakeholders that include local hospitals, airports and community agencies.

Up-to-date information regarding:

Health care settings are being requested to conduct passive and active screening of anyone entering the premises, as detailed by the Ontario Ministry of Health’s COVID-19 Patient Screening Guidance Document.

If this document does not contain information specific to your healthcare setting, please see other documents in the Ontario Ministry of Health’s Health Sector Resources.

For more information on the types of testing available and how to get tested:

For guidance about testing:

The following may be used to obtain COVID-19 test results:

If you are not providing COVID-19 vaccine in your practice, you can direct your patients to book their vaccine appointment using the Province’s registration system or by calling 1-833-943-3900 (TTY 1-866-797-0007 OR visiting TPH’s COVID-19 Where to Get Vaccinated.

Ordering Vaccine for your Practice

To order Pfizer-BioNTech and Moderna COVID-19 vaccines, complete the TPH COVID-19 Vaccine Program Enrollment Request Form and the onboarding process. Please only complete this form once for each primary care or general pediatric practice. Once complete, access to the ordering portal will be provided.

Email questions about enrolling in the Toronto Primary Care COVID-19 Vaccine Program to

To learn more about providing COVID-19 vaccines in-office, see the Information for Health Professionals Providing COVID-19 Vaccines In-Office fact sheet.

Billing OHIP for Administration of COVID-19 Vaccine

The Ontario Medical Association (OMA) details of billing (OMA login required to access PDF) for activities related to COVID-19 vaccination. Members should check the OMA portal regularly for updates.

Physicians with questions pertaining to the submission of these billing codes should email the Ministry’s Service Support Contact Centre at

Referrals for non-mRNA COVID-19 Vaccines

A primary care provider referral is no longer required to receive Novavax COVID-19 vaccines. TPH has updated its appointment booking process to reflect this change.


All individuals aged 6 months and up are eligible to receive a COVID-19 vaccine.

Visit the COVID-19: Vaccinate Eligibility & Doses page to learn more about first doses, second doses, booster doses, including recommendations for immunocompromised individuals and post-transplant re-vaccination.

COVID-19 Vaccine after Previous COVID-19 Infection

The Ontario Ministry of Health, in alignment with NACI, continues to recommend that COVID-19 vaccines should be offered to individuals with previous SARS-CoV-2 infection without contraindications to the vaccine. Below are suggested intervals between previous SARS-CoV-2 infection and COVID-19 vaccination:

If completing a primary series:

  • 2 months for individuals who are not immunocompromised and have no history of multisystem inflammatory syndrome in children (MIS-C)
  • 1 to 2 months (28 to 56 days) for immunocompromised individuals with no history of MIS-C
  • for individuals with a history of MIS-C, until clinical recovery has been achieved or up to 90 days since the onset, whichever is longer, regardless of immunocompromised status

If getting a booster dose:

  • 6 months after positive COVID-19 test or after having symptoms post contact with someone who had a positive test

For more information visit:

Reporting Adverse Events Following Immunization (AEFI)

An AEFI is an unwanted or unexpected health effect that happens after someone receives a vaccine, which may or may not be caused by the vaccine. A causal relationship does not need to be proven before reporting. Of particular interest are unusual or unexpected events, or serious reactions requiring urgent care.

Toronto health care providers are required to report all Adverse Events Following Immunization (AEFI) to TPH under the Health Protection and Promotion Act.

Complete the AEFI Reporting Form and fax it to 416-696-3492 or email it to

To stay up-to-date about AEFIs reported following COVID-19 vaccinations, visit the Public Health Agency of Canada’s weekly report, Reported side effects following COVID-19 vaccination in Canada, regularly.

More information about COVID-19 vaccines can be found at:

The Ministry of Health has published guidance to assist health care providers evaluate contraindications or precautions to COVID-19 vaccination that may warrant a medical exemption. Refer to Table 1 for details.

True medical exemptions are expected to be infrequent and should be supported by expert consultation. Referral and specialist consultation support for physicians and nurse practitioners is available through Ontario’s eConsult Service, OTN Hub, and the Special Immunization Clinic (SIC) Network. In many instances, safe administration of subsequent doses of COVID-19 vaccine is possible under the management of an allergist/immunologist.

Individuals with medical exemptions for COVID-19 vaccinations approved and entered into CovaxON may obtain an enhanced vaccination certificate with a QR code under Ontario’s Proof of Vaccination Policy.

Exemption forms may be submitted by secure fax to 416-338-2487. Submissions must:

  • Be on the Ministry of Health medical exemption template (letters and other submission formats will not be accepted)
  • Be submitted by an Ontario physician (MD) or registered nurse in the extended class (“Registered Nurse (Extended Class)”, “RN(EC)”, “Nurse Practitioner” or “NP”) based in Toronto
  • Comply with Ministry guidance with respect to clinical assessment and exemption types
  • Confirm the patient’s consent to collect, use and disclose their personal health information to TPH
  • If submitting multiple patients’ exemptions, fax each request separately (cover sheet not necessary)

If there is an issue with the submission, TPH will follow up with the medical practitioner.

TPH will provide a confirmation e-mail to the submitting practitioner following entry of the medical exemption into COVaxON. Operational demands related to rising case numbers may result in significantly reduced capacity to enter medical exemptions. Given this, response time estimates are currently unavailable. Once the submission form has been processed by TPH, patients will be able to download an enhanced vaccination certificate with a QR code that indicates their exemption for use in settings requiring vaccine certificates to enter or participate.

Exemptions Due to Participation in a Clinical Trial

Exemptions due to participation in a clinical trial should be sent directly to the Ministry of Health, at, by the Principal Investigator or Study Director of the trial, and not to TPH.

COVID-19 Outbreaks

COVID-19 outbreaks in institutional facilities are reportable to the local public health unit. Long-term care homes are also required to report COVID-19 outbreaks to the Ministry of Long-Term Care (MOLTC).

To report a suspected or confirmed COVID-19 outbreak:

Business Hours (weekdays 8:30 a.m. to 4:30 p.m.):
  • Communicable Disease Liaison Unit (CDLU) facilities: contact your CDLU Liaison directly or the CDLU General Line: 416-338-2100 or
  • Long-Term Care and Retirement Homes Congregate Team (LRCT): send an email to
After Hours (weekdays after 4:30 p.m., weekends and statutory holidays):
  • Call 3-1-1 or 416-392-CITY (2489) and ask for the on-call Communicable Diseases Control (CDC) Manager
  • The mailbox will not be monitored during after hours from 4:30 p.m. to 8:30 a.m. on weekends or on statutory holidays. Messages directed to this mailbox will be actioned on the next business day.

Outbreak Forms and Instructions



Please follow the Ontario Science Table Guidance: Therapeutic Management of Residents of Long-term Care Homes with COVID-19.

Please also visit the Treatment section of the COVID-19 Information for Health Professionals below.


While we aim to provide fully accessible content, there is no text alternative available for some of the content on this site. If you require alternate formats or need assistance understanding our maps, drawings, or any other content, please contact us at

Ministry of Health (MOH) Resources


Retirement Home Resources

Public Health Ontario (PHO) Resources


COVID-19 treatments are available. Individuals must have a positive COVID-19 test to receive treatment (PCR or rapid antigen test [including self-administered]). COVID-19 medications are recommended for patients who present within 5 days (Paxlovid) or 7 days (Remdesivir) of symptom onset.

Individuals who may be eligible for treatment and have an initial negative rapid antigen test result are strongly recommended to seek laboratory-based or rapid molecular testing as soon as possible given the short time frame for receiving therapeutics.

For more information on antiviral treatments for COVID-19 visit:


For information on how primary care providers and other health care providers can access Paxlovid for patients in the community please see Ontario Health’s Access to COVID-19 antiviral treatment (Paxlovid).


As per the direction from the Ontario Ministry of Health, access to Remdesivir intravenous antiviral therapy for COVID-19 is now provided via the province’s Home and Community Support Services (HCCSS) organizations.

In Toronto, virtual clinical assessments and referral/prescribing of Remdesivir continues to be supported by the UHN Connected Care Hub.

As of November 2022, Ontario Health does not recommend Evusheld for pre-exposure prophylaxis or treatment of COVID-19 for any patient group, including immunocompromised patients.


Reporting Probable and Confirmed Cases

Probable and confirmed cases of COVID-19 must be reported to Toronto Public Health by telephone at 416-392-7411 (after hours: 311), or by faxing TPH’s Communicable Disease Reporting Form to 416-696-3477.

Note: Hospitals and Assessment Centres

  • Hospitals and COVID-19 assessment centres must continue to report laboratory-confirmed cases of COVID-19 to TPH by fax only: 416-696-3477.
  • Please ensure an appropriate specimen was collected for COVID-19 testing and the patient is advised to self-isolate until their results are available.

Reporting Adverse Events Following Immunization (AEFI)

Complete the AEFI Reporting Form and fax it to 416-696-3492 or email it to